🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

How can we kill chemo-resistant glioma cells? Turns out they are uniquely vulnerable to #ferroptosis. Awesome collaboration with Columbia Translational Brain Tumor Laboratory Matei Banu combining a new mouse glioma model with human glioma slice culture/scRNA-seq: biorxiv.org/content/10.110…

Huge thank you to the @Lancet for visiting our lab and giving us the opportunity to showcase some of our current work tackling glioma heterogeneity via ferroptosis! Peter Canoll Matei Banu Michael Argenziano Peter Sims

Excited to share my thoughts on our new paper in Nature Communications with Peter Canoll, Jeff Bruce, Simon Cheng and our lab members on a #precision #diet that promotes #ferroptosis in #brain #cancer @columbia Columbia University_Bio medium.com/@brentstockwel…

Really happy to share our new paper published in Nature Communications, an amazing collaboration with Brent Stockwell lab and others, demonstrating that cysteine/methionine deprivation can sensitize glioma cells to a form of cell death called ferroptosis nature.com/articles/s4146…

Excited that our new paper in Nature Communications is also highlighted in PNAS journal club Peter Canoll Brent Stockwell pnas.org/post/journal-c…

Congratulations to our 2023 Columbia Neurosurgery matches! Michael G. Argenziano, MS, MD, Adrian Jimenez MD, and Amitra K. Singh, MD!

Epic #Match2023 for Sims lab MD/PhD alums with Ben Hobson returning to his home state for psychiatry @CUAnshutz and Jordan Metz staying in his home state Columbia Pathology. Couldn't be more proud! Can't wait to see what they do next.

A form of cell death discovered 10 years ago at Columbia could help scientists design better, more targeted therapeutics to treat illnesses like cancer, write Professors @BStockwell and Wei Min in a new paper. bit.ly/3JNLIQz

Huge congratulations to all of the Bruce-Canoll lab medical students (Colin, Adi, Cole, and Will) who presented their research at Columbia Vagelos College of Physicians & Surgeons Student Research Day today! Amazing work! 👏

Outstanding talk by ⁦Michael Argenziano⁩ at #AANS2023 presenting our work on #GBM and #ferroptosis demonstrating how we can target resistant cancer cells. Learning from clinical trials to advance therapy! So proud of Michael, physician scientist superstar!

Check out our new review article just published in Neuro-Oncology Advances Editor - Neuro-Oncology Advances on local delivery of immunomodulatory therapy for high grade glioma led by Colin Sperring et al academic.oup.com/noa/advance-ar…

Awesome work Colin Sperring and Michael Argenziano!

Check out our team's highlights from #AANS2023 neurosurgery.columbia.edu/news/columbia-…

Excellent work from Osama Al Dalahmah & Michael Argenziano & Adithya Kannan et al just published in Nature Communications !

Congratulations to Dr. Nina Teresa Yoh, on receiving the 2023 Conquer Cancer, the ASCO Foundation – The Sontag Foundation Young Investigator Award! 🏆🔬 Study Title: "Using Focused Ultrasound to Open the Blood-Brain Barrier for Liquid Biopsy; A Study in Children with Progressive Diffuse Midline #Glioma"

Dr. Nina Teresa Yoh won the Conquer Cancer, the ASCO Foundation Young Investigator Award for her research on Focused Ultrasound to open the Blood-Brain Barrier for liquid biopsy in children w/ Progressive DMG, potentially revolutionizing pediatric #braintumor treatment. 👏 Read 👉ow.ly/E04L50OIz3s